describ
elsewher
issu
microbiolog
evid
infect
must
consid
context
sever
fundament
difficulti
found
respiratori
diagnost
includ
frequent
lack
access
site
infect
insensit
avail
test
insuffici
assay
valid
complex
determin
whether
detect
pathogen
causal
role
ill
specif
researchrel
demand
perch
ad
constraint
requir
diagnost
strategi
must
exclud
prior
assumpt
regard
like
import
specif
pathogen
must
includ
full
rang
respiratori
tract
specimen
includ
upper
respiratori
swab
aspir
induc
sputum
lung
aspir
bronchoalveolar
lavag
pleural
fluid
must
comprehens
yet
realist
must
appropri
balanc
demand
accuraci
effici
must
account
clinic
research
ethic
issu
must
feasibl
use
support
particip
field
site
begin
select
process
perch
investig
conduct
extens
review
microbiolog
diagnosi
respiratori
infect
use
publish
unpublish
data
well
user
develop
experi
team
prepar
strateg
summari
avail
technolog
could
detect
pathogen
respiratori
tract
specimen
evalu
major
assay
categori
includ
tradit
bacteriolog
viral
cultur
direct
antigen
immunofluoresc
antibodi
detect
nucleic
detect
acid
test
evid
molecular
diagnost
among
mix
diagnost
tool
requir
meet
need
perch
nucleic
acid
detect
test
nadt
number
advantag
diagnost
platform
evalu
respiratori
specimen
demonstr
superior
sensit
detect
organ
fastidi
less
viabl
present
small
amount
molecular
diagnost
also
quickli
adapt
detect
evolv
emerg
pathogen
amen
effici
scale
autom
also
allow
simultan
detect
multipl
target
multiplex
turn
allow
test
clinic
syndrom
detect
coinfect
nadt
method
present
less
safeti
hazard
laboratori
personnel
compar
cultur
typic
requir
less
time
compar
bacteri
cultur
requir
less
technic
capac
compar
viral
cultur
given
advantag
nadt
extens
evalu
detect
sever
virus
bacteria
respiratori
tract
becom
diagnost
tool
choic
mani
agent
difficult
isol
molecular
diagnost
platform
without
disadvantag
cost
complex
remain
signific
barrier
adopt
mani
laboratori
nadt
often
risk
problem
laboratori
contamin
amplifi
product
particularli
assay
procedur
requir
open
reaction
tube
prior
target
detect
step
measur
limit
contamin
often
requir
addit
laboratori
space
may
avail
resourceconstrain
set
nevertheless
nadt
method
repres
one
product
area
diagnost
research
promis
futur
improv
autom
speed
smaller
devic
improv
cost
effici
better
detect
emerg
pathogen
focu
molecular
method
respiratori
pathogen
detect
yield
larg
varieti
potenti
technolog
consider
perch
tabl
polymeras
chain
reaction
pcr
technolog
common
research
site
worldwid
adapt
variou
platform
easili
allow
multiplex
amplif
multiplex
sever
target
assay
simultan
commonli
employ
pcrbase
assay
offer
signific
advantag
singlepathogen
assay
term
effici
pathogen
coverag
still
develop
must
overcom
consider
complex
harmon
reaction
requir
individu
target
limit
potenti
competit
among
analyt
factor
may
result
measur
decreas
sensit
compar
singleplex
assay
sever
techniqu
develop
address
factor
alter
cycl
protocol
nest
primer
combin
complex
primer
structur
concentr
use
nontradit
nucleotid
nadt
technolog
nucleic
acid
sequencebas
amplif
loopmedi
isotherm
amplif
use
detect
respiratori
pathogen
experi
multiplex
limit
technolog
target
detect
take
even
larger
varieti
format
older
method
includ
agaros
gel
electrophoresi
reversetranscript
pcr
enzym
hybrid
assay
enzymelink
oligonucleotid
captur
recent
solid
liquidphas
array
platform
becom
use
detect
multipl
target
solidphas
array
use
varieti
format
typic
embed
targetspecif
oligonucleotid
onto
glass
silicon
microchip
detect
anywher
dozen
hundr
thousand
amplifi
sequenc
sever
respiratori
diagnost
system
base
liquidphas
technolog
use
polystyren
microbead
luminex
mass
spectroscopi
amplicon
discrimin
although
approach
greatli
expand
versatil
sensit
multiplex
pcr
complex
special
equip
high
startup
cost
limit
widespread
adopt
date
moreov
platform
typic
requir
separ
step
amplif
detect
increas
workload
risk
oper
error
amplicon
contamin
realtim
pcr
assay
address
issu
combin
amplif
detect
one
reaction
tube
thu
facilit
autom
reduc
contamin
addit
techniqu
allow
quantif
pathogen
assess
replic
effici
convent
pcr
multiplex
realtim
assay
subject
competit
inhibit
among
primer
realtim
assay
also
restrict
number
reaction
product
detect
parallel
although
problem
partial
circumv
use
array
uniplex
realtim
reaction
small
volum
success
inhous
realtim
assay
direct
respiratori
pathogen
develop
use
uniplex
multiplex
approach
data
perform
commerci
version
readili
avail
much
effort
nadt
develop
respiratori
diagnost
focus
detect
virus
given
advantag
techniqu
convent
method
term
speed
sensit
versatil
detect
class
pathogen
multiplex
approach
viral
detect
becom
common
technolog
improv
review
addit
nadt
becom
gold
standard
detect
mycoplasma
pneumonia
chlamydophila
pneumonia
use
addit
antigen
test
legionella
speci
multiplex
assay
detect
tradit
bacteri
pathogen
studi
frequent
respiratori
specimen
primarili
cultur
techniqu
usual
adequ
clinic
practic
moreov
molecular
method
provid
addit
advantag
cultur
differenti
infect
colon
upper
respiratori
tract
nevertheless
multiplex
nadt
bacteria
pneumonia
haemophilu
influenza
streptococcu
pyogen
evalu
respiratori
specimen
like
incorpor
larger
multiplex
assay
conduct
survey
field
narrow
list
candid
molecular
diagnost
platform
even
basi
uniqu
need
research
studi
clinic
laboratori
close
examin
factor
cost
feasibl
qualiti
assur
capit
invest
platform
versatil
futur
util
contrast
clinic
laboratori
consid
issu
rapid
return
result
regulatori
approv
use
patient
care
less
crucial
object
moreov
approach
emphas
comprehens
pathogen
detect
rather
focus
primarili
pathogen
relev
clinic
manag
infect
control
final
select
platform
would
deploy
lowresourc
set
requir
reliabl
continu
power
suppli
adequ
access
reagent
sensit
extrem
environment
condit
access
technic
support
would
highli
relev
apprais
progress
encount
mani
challeng
interpret
common
field
diagnost
evalu
basic
among
confus
regard
usag
term
sensit
specif
evalu
need
measur
paramet
distinct
analyt
perform
characterist
oppos
diagnost
clinic
perform
characterist
essenti
properli
assess
valid
assay
particularli
true
field
molecular
diagnost
nadt
analyt
sensit
refer
lowest
concentr
target
detect
wherea
analyt
specif
measur
abil
test
exclud
undesir
target
despit
similar
genet
sequenc
contrast
diagnost
clinic
sensit
nucleic
acid
detect
test
refer
appropri
identif
patient
carri
agent
diagnost
clinic
specif
describ
assay
abil
exclud
uninfect
patient
clinic
perform
characterist
subject
number
factor
includ
patient
diseas
statu
variat
concentr
target
throughout
cours
ill
inhibit
substanc
present
specimen
sampl
qualiti
sampl
variabl
specimen
degrad
gener
assay
test
refer
gold
standard
test
microbi
detect
refer
standard
typic
cultur
molecular
diagnost
often
much
sensit
detect
nucleic
acid
cultur
viabl
organ
lead
difficulti
interpret
clinic
relev
falseposit
result
challeng
assess
diagnost
test
increasingli
recogn
recent
year
instanc
standard
report
diagnost
accuraci
initi
offer
guidelin
report
diagnost
studi
wherea
qualiti
assess
tool
diagnost
accuraci
studi
provid
correspond
guidanc
evalu
nevertheless
respiratori
diagnost
particularli
limit
inabl
determin
whether
detect
particular
pathogen
symptomat
patient
indic
caus
ill
result
contamin
colon
prolong
shed
prior
unrel
infect
particularli
test
specimen
upper
respiratori
tract
issu
typic
address
diagnost
evalu
studi
becom
relev
molecular
diagnost
expand
lower
limit
pathogen
detect
sever
order
magnitud
attempt
answer
question
suggest
addit
categori
test
perform
epidemiolog
specif
test
describ
abil
assay
assign
true
etiolog
statu
pathogen
specif
ill
ultim
determin
epidemiolog
specif
respiratori
diagnost
would
requir
interpret
microbiolog
result
conjunct
clinic
laboratori
data
perhap
form
predict
model
analys
uncommon
main
focu
perch
studi
respiratori
diagnost
complic
absenc
perfect
gold
standard
cultur
difficult
insensit
pathogen
unavail
other
eg
human
metapneumoviru
parainfluenzaviru
type
rhinoviru
group
c
pneumocysti
jiroveci
serolog
test
often
avail
usual
requir
pair
serum
specimen
accur
result
statist
method
adjust
alloy
gold
standard
discrep
analysi
frequent
employ
suscept
signific
bia
compar
evalu
respiratori
diagnost
assay
must
also
take
account
variat
panel
pathogen
select
genet
sequenc
target
specimen
sourc
use
even
method
use
nucleic
acid
extract
us
food
drug
administr
recent
publish
industri
guidanc
may
encourag
addit
work
area
perch
evalu
progress
concept
deriv
deliber
distil
list
desir
essenti
attribut
summar
strategi
evalu
tabl
list
address
issu
assay
perform
rang
target
accept
specimen
sourc
sensit
specif
oper
concern
space
requir
assay
throughput
qualiti
assur
program
mainten
requir
reagent
avail
strateg
issu
capac
autom
versatil
futur
util
startup
mainten
cost
develop
engag
addit
input
present
summari
pneumonia
method
work
group
expert
committe
form
advis
perch
ultim
outlin
key
qualiti
data
allow
us
articul
thought
commun
strategi
effect
collabor
advisor
assay
develop
appli
list
attribut
dozen
candid
diagnost
system
met
initi
criteria
develop
short
list
candid
platform
test
final
assay
perchaffili
laboratori
use
standard
set
mock
specimen
process
allow
us
engag
assay
manufactur
academ
partner
directli
compar
perform
characterist
platform
gain
essenti
inform
could
acquir
handson
experi
capabl
technolog
transfer
eas
use
workflow
detail
evalu
subject
separ
articl
includ
phase
protocol
develop
perch
investig
abl
perform
extens
literatur
review
respiratori
diagnost
clearli
outlin
major
theoret
practic
concern
engag
group
expert
critic
input
process
confirm
suitabl
molecular
diagnost
need
identifi
critic
inform
gap
evalu
highlight
numer
advantag
technolog
includ
excel
sensit
adapt
full
rang
respiratori
pathogen
specimen
sourc
well
clear
capabl
multiplex
autom
nevertheless
realiz
conclus
repres
snapshot
time
field
molecular
diagnost
rapidli
evolv
constant
improv
accuraci
speed
autom
cost
yet
also
expect
method
evalu
respiratori
diagnost
continu
evolv
parallel
provid
new
answer
practic
conceptu
challeng
shape
develop
diagnost
test
strategi
perch
